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ABSTRACT

Sick, Justin T. Ph.D., Purdue University, August 2016. Ultrasound and Photoacoustic
Methods for Anatomic and Functional Imaging in Image Guided Radiation Therapy.
Major Professor: Keith Stantz.

(PURPOSE) The goal of this research is to develop image-guided radiotherapy
techniques based on ultrasound and photoacoustic instrumentation and methods.
(INTRODUCTION) A critical problem in RT is the intra and inter-fractional
changes in the target geometry, positioning, and biology, which can impact tumor control
and systemic toxicity. Unlike other imaging modalities, ultrasonic-based imaging
techniques provides real-time, high resolution imaging of a patient’s anatomy and tumor
physiology and hypoxia without the use of ionizing radiation. In the following studies,
technical studies are performed to integrate 3D ultrasound into the IMRT treatment
planning of dogs with bladder cancer, in effect, replacing CBCT, and feasibility studies
performed to determine if photoacoustic imaging can be used to monitor changes in
oxygen saturation levels.
(MATERIAL and METHODS) First, we define the physical principals and
optimal protocols that provide contrast when imaging with US and the transducer
properties contributing to resolution limits. The US field of view (FOV) was

xi
characterized to determine the optimal settings with regard to imaging depth, focal
region, with and without harmonic imaging, and artifact identification. This will allow us
to determine the minimum errors expected when registering multimodal volumes (CT,
US, CBCT).
Next, we designed an in-house integrated US manipulator and platform to relate
CT, 3D-US and linear accelerator coordinate systems. To validate our platform, an agarbased phantom with measured densities and speed-of-sound consistent with tissues
surrounding the bladder was fabricated. This phantom was rotated relative to the CT and
US coordinate systems and imaged with both modalities. These CT and 3D-US images
were imported into the treatment planning system, where US-to-US and US-to-CT
images were co-registered and the registration matrix used to re-align the phantom
relative to the linear accelerator. The measured precision in the phantom setup, which is
defined by the standard deviation of the transformation matrix components, was
consistent with and exceeding acceptable clinical patient re-alignments (2 mm).
Statistical errors from US-US registrations for different patient orientations ranged from
0.06-1.66 mm for x, y, and z translational components, and 0.00-1.05 degrees for
rotational components. Statistical errors from US-CT registrations were 0.23-1.18 mm for
the x, y and z translational components, and 0.08-2.52 degrees for the rotational
components. The high precision in the multimodal registrations suggest the ability to use
US for patient positioning when targeting abdominal structures. We are now testing this
on a dog patient to obtain both inter and intra-fractional positional errors.
The objective of this experiment is to confirm Hill’s equation describing the
relationship between hemoglobin saturation (SaO2) and the partial pressure of dissolved
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oxygen (pO2). The relationship is modeled as a sigmoidal curve that is a function of two
parameters – the Hill coefficient, n, and the net association constant of HbO2, K (or pO2
at 50% SaO2). The goal is to noninvasively measure SaO2 in breast tumors in mice using
photoacoustic computed tomographic (PCT) imaging and compare those measurements
to a gold standard for pO2 using the OxyLite probe. First, a calibration study was
performed to measure the SaO2 (co-oximeter) and pO2 (Oxylite probe) in blood using
Hill’s equation (P50=23.2 mmHg and n=2.26). Next, non-invasive localized
measurements of SaO2 in MDA-MD-231 and MCF7 breast tumors using PCT
spectroscopic methods were compared to pO2 levels using Oxylite probe. The fitted
results for MCF7 and MDA-MD-231 data resulted in a P50 of 17.2 mmHg and 20.7
mmHg and a n of 1.76 and 1.63, respectively. The lower value of the P50 is consistent
with tumors being more acidic than healthy tissue. Current work applying photon fluence
corrections and image artifact reduction is expected to improve the quality of the results.
In summary, this study demonstrates that photoacoustic imaging can be used to monitor
tumor oxygenation, and its potential use to investigate the effectiveness of radiation
therapy and the ability to adapt therapeutic protocols.
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CHAPTER 1. INTRODUCTION

1.1 Advantages of the Canine Model
New animal models better representing invasive bladder cancer in humans are
needed before translating experimental treatments from the laboratory into the clinic1.
Spontaneous invasive transitional cell carcinoma (TCC) is the most common cancer of
the canine urinary system and is only partially responsive to treatment with surgical
resection or systemic chemotherapy. Radiation therapy (RT) is made technically difficult
by the considerable internal variations in bladder size, shape and position2. The
advantages of canine model systems were described previously1 and have been applied to
TCC. Knapp, et al.3 offered some of these benefits which include: 1) similarities in
histopathologic appearance, biological behavior and response to therapy in both canine
cancer and human cancer, 2) dogs and humans have similar drug metabolism, 3) standard
treatments are less defined for many canine cancers, therefore fewer constraints are
placed on testing new therapies, 4) the compressed lifespan of canines makes for shorter
clinical trials, 5) canines have similar exposures to toxins as humans due to shared living
space, 6) testing translatable technologies is more feasible on animals closer to the size of
humans, and 7) novel interventional strategies established in vitro or in laboratory animal
studies can be verified in vivo in spontaneous tumor-bearing dogs. The investigation of
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spontaneous cancer is also more tolerable to a general public worried about animal
welfare than inducing disease in animals for examination.

1.2 Radiation Therapy
The use of radiation to target cancer was recognized early after the discovery of xrays4. Rapid advancements in accelerator technology have made feasible the delivery of
x-rays to tumor volumes in addition to reducing accumulative healthy tissue dose.
Improvement of RT progressed quickly during the 20th and 21st centuries, starting with
3D conformal radiation therapy (CRT), to intensity modulated radiation therapy (IMRT),
to stereotactic radiosurgery (SRS) and more recently, tomotherapy. Developments in
high-quality imaging systems are necessary to deliver more conformal RT.
Where early therapy sessions included a single pre-treatment CT for simulation,
new advancements have allowed for constant monitoring of patient anatomy throughout
the treatment process. The method of frequent two and three-dimensional imaging
throughout a course of radiation treatment used to direct RT is termed image-guided
radiation therapy (IGRT). Radiation treatment incorporating any number of imaging
modalities to systematically modify the treatment plan is termed ‘adaptive radiation
therapy’ (ART). Image-guided adaptive radiotherapy (IGART) has the possibility to
lessen the adverse effects from inter- and intra-fractional geometric and biologic
fluctuations. There are three phases during the sequence of the radiotherapy process
where imaging is used: 1) patient data acquisition; 2) patient setup for treatment; 3)
during treatment to monitor organ motion.
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1.3 Standard IGRT imaging techniques
The specialized improvement of imaging hardware and software intended to
visualize internal anatomy during treatment has become an area of active research5,6. The
typical IGRT technologies include kilovoltage (kV) and megavoltage (MV) portal and
radiographic imaging systems and in-room computed tomography (CT).
Electronic portal imaging has been the preferred tool for online verification of
patient setup in the past decades7. Portal imaging is the acquisition of images with the
treatment beam; typically two or more directions are acquired before the delivery of
radiation8. The portal images are compared to digitally reconstructed radiographs to
ensure the patient is in the ideal setup position. In sites where there is little tumor motion
with respect to the bony anatomy, such as the head and neck, the bones can be used for
the reference. For treatment locations where organ motion is significant, fiducial markers
implanted in the tumor volume or near it can be seen on the portal images and used as the
reference. Although the kV images have better contrast than the MV images, neither of
them is of sufficient quality to visualize soft-tissue targets in their entirety. Additionally,
they typically require independent X-ray sources and detectors, consequently introducing
an element of uncertainty between the imaging and beam iso-centers as well as an
additional cost to therapy centers.
The widespread availability CT in the field of radiation oncology makes daily
visualization and localization of soft tissue anatomy in the therapy suite prior to delivery
of treatment commonplace. These advancements have highlighted the ability to improve
treatment accuracy with respect to patient positioning. A number of types of in-room CT
imaging systems are now available. A few examples include a ‘CT on rails’ system
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consisting of a conventional CT scanner located in the treatment vault on the same couch
as the linear accelerator, kV cone-beam CT (CBCT) composed of an additional
diagnostic kV source and a flat-panel detector mounted orthogonally to the treatment
head and MV CBCT systems using the pre-existing treatment machine and an electronic
portal imaging device9.

1.4 Managing imaging dose
Image-guided RT makes use of a variety of different radiographic modalities to
monitor patient position and organ motion. All radiographic guidance techniques share
the fact that they can give a considerable radiation dose to the patient. As a result, the
American Association of Physicists in Medicine assigned a task group to determine
guidelines for managing imaging dose9. This report concluded that as a result of the many
different imaging techniques used in IGRT, including different modalities (portal
imaging, fluoroscopy, kV and MV-CBCT and multiple conventional CT scans) as well as
the various time frames the dose is received by the patient (weeks for conventional RT,
days for hypo-fractionated RT and radiosurgery), it is not accurate to assume the
cumulative imaging dose is trivial when compared to the therapeutic dose.

1.5 In-vivo molecular imaging
In-vivo models including complete physiologic processes such as multiple organ
interactions, angiogenesis and the immune system are necessary to improve current invitro models3. Dynamic contrast-enhanced CT (DCE-CT), dynamic contrast enhanced
magnetic resonance imaging (MRI) (DCE-MRI), positron emission tomography (PET)
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and single-photon emission tomography (SPECT) have been extensively used for in vivo
measurement of tumor vascular physiology10,11.
PET and SPECT imaging monitor an injectable radioisotope tracer to evaluate
function, such as metabolic activity using 18-FDG, and a CT scan to provide spatial
information about the tracer uptake. PET/CT is a promising diagnostic innovation and is
the standard of care monitoring modality in human malignancies. Unfortunately, there are
many disadvantages to the use of PET/CT. Patients, staff, family members and the
general public are potentially exposed to these radioactive isotopes. The amount of
ionizing radiation involved is non-trivial and especially concerning when the diagnostic
intervention is proposed for at-risk populations of cancer patients such as children.
Instead, photoacoustic tomography (PAT) is a nonionizing and noninvasive
imaging modality employing laser-induced ultrasonic signals within biological tissue.
This imaging method merges the high resolution of ultrasonic signals with the contrast
being provided by optical scattering and absorption. This allows for non-invasive
structural and functional imaging in-vivo12.

1.6 Therapeutic targets
Ionizing radiations stimulates both pro- and anti-proliferative signal pathways
generating an imbalance in cell survival decision controlled by a number of genes and
factors involved in cell cycle progression, survival and/or cell death, DNA repair and
inflammation13. The body’s reaction to cancer resembles inflammation and wound
healing14. The idea of the immune system identifying and targeting mutated cells as a
result of a particular immune reaction to the tumor, causing inflammation, is
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demonstrated by recent evidence15. Alternatively, inflammation promotes the release of
pro-inflammatory cytokines, some of which may stimulate tumor progression16. The most
likely scenario is that tumor-promoting inflammation and anti-tumor immunity co-exist
during the course of tumor progression and conditions in the tumor environment
influence the balance between the two17.
Assessment of the molecular and functional features of tumors may allow the
characterization of local weaknesses that can be exploited to focus treatment strategies.
Although tumor masses regularly appear homogeneous on CT scans, this is rarely the
case. Heterogeneity in viable and necrotic tissue, angiogenesis and anoxia, rate of cellular
growth and cell death, as well as receptor and antigen expression frequently go
undetected18. Various signals that control angiogenesis include low partial oxygen
pressure (pO2), low pH or hypoglycemia as a consequence of metabolic trauma, increased
pressure in the stroma due to proliferating cells, an immune/inflammatory response and
genetic mutations19. All of these features are very important in determining the stage and
therapeutic resistance of the tumor and in principle, assessing these features could be
extremely helpful for developing new treatment strategies.

1.7 Hypothesis
The purpose of IGRT is to track organ motion in real-time to monitor treatment
uncertainties. In general, these uncertainties all into two categories physical and
physiological, and they manifest themselves in margins expanded from the tumor
volume. The underlying problem with this procedure is planning to give the healthy
surrounding tissue a lethal dose to ensure tumor control, especially when the limiting
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factor of RT is healthy tissue toxicity. Therefore, incorporating imaging systems to
reduce planning margins will limit radiation induced side effects. Additionally,
visualizing the heterogeneity of the tumor and planning treatments to apply focused daily
boosts of radiation and re-evaluating conventional fractionation will increase the
therapeutic ratio of the dose being delivered, and in turn, improve tumor control.
Our goal is two-fold: 1) to accurately track the bladder during RT of canine TCC
through daily 3D transabdominal US and 2) to concurrently image intra-tumor variations
in hypoxia in these same patients. With these tools, both geometric and molecular
features can be monitored in real-time and used to investigate and adapt radiation therapy
in these patients. Therefore, the goal of this research is to develop image-guided
radiotherapy techniques based on ultrasound (US) and photoacoustic (PA)
instrumentation and methods.
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CHAPTER 2. SPECIFIC AIMS

2.1 Specific Aim 1
Quantify the resolution of 3D US imaging systems. The purpose of this section
is to define the physics that provides contrast when imaging with US and the transducer
properties contributing to resolution limits. Next, the US field of view (FOV) will be
characterized to determine the optimal settings with regard to imaging depth, focal
region, with and without harmonic imaging, and artifact identification. This information
will provide a basis from which to compare our phantom studies in the studies to volume,
including the minimum errors expected when registering multimodal volumes (CT, US,
CBCT).

2.2 Specific Aim 2
Design, construct and commission a platform for US imaging in combination
with CT. The platform provides a reproducible positional frame of reference for targeting
an anatomic structure. The platform will interlock with Varian exact couch index points
and CT diagnostic scanner for reproducibility of positioning. The platform will be imaged
for all discrete positions (via CT scanner), where discrete angles will be measured and
saved within a MATLABTM graphical user interface (GUI). The platform will be calibrated
to the coordinate system of
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the linear accelerator. Our objective is to obtain CT and US alignment errors within or
better than cone-beam computed tomography (CBCT), which is ±2mm.
Given the translational validation of the US for clinical treatment of canine
patients, our focus is toward the feasibility of using PCT to provide new imaging
properties and link this to tumor radiation sensitivity and immune response of the patient.

2.3 Specific Aim 3
Validate hemoglobin saturation and dissolved oxygen in tumors using
photoacoustic spectroscopic imaging. This pilot study investigates the method to
measure SaO2 levels in mice and examines the feasibility to translate photoacoustic
tomographic imaging in to a canine model. First, a calibration study to validate Hill’s
equation in blood will be performed by creating a closed circuit blood-flow phantom to
test the relationship between SaO2 (co-oximeter) and pO2 (Oxylite probe). Next, noninvasive localized measurements of SaO2 in MDA-MD-231 and MCF7 breast tumors
using PCT spectroscopic methods will be compared to pO2 levels (Oxylite probe) in vivo.
Finally, the design concept of photoacoustic tomographic imaging in a canine model will
be explored.

2.4 Innovation and Impact
By using real-time motion tracking through US-based anatomical information and
PA molecular imaging, treatment margins can be reduced, which will improve tumor
control and reduce normal tissue radiation toxicity. The proposed innovative design
combines 3-D US and PA imaging in a single system that can be integrated onto RT
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treatment bed. The whole system, minus the transducer, will be primarily fabricated using
3D printing techniques using low Z material so it is not to interfere with CT simulation
and RT. The US imaging will provide real-time images without the use of ionizing
radiation. We anticipate PA imaging will impact RT in two ways: 1) it will increase the
accuracy when delineating the tumor margins by identifying the vasculature at the
periphery of the tumor, and 2) provide the means to characterize the tumor with spatial
and molecular information in the tumor and normal structures. The day-to day (inter- and
potential intra-fraction) information afforded by US and PA images will allow for
adaptive radiotherapy treatment planning based on molecular and functional imaging such as hypoxia (via SaO2) and perfusion (contrast-enhanced PCT; microbubble
enhanced US), cytokine production, and potentially hypoxic type (cycling versus
chronic).
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CHAPTER 3. QUANTIFY THE RESOLUTION OF 3D US IMAGING SYSTEMS

3.1 Introduction
The method of frequent two and three-dimensional imaging throughout a course
of radiation treatment used to direct RT is termed image-guided radiation therapy
(IGRT). In essence, imaging devices are used by the radiation therapy team as tools to
verify patient setup and provide a means for the safe delivery of treatment. The standard
for simulation and treatment planning is computed tomography (CT) to obtain anatomical
electron distributions followed by cone-beam computed tomography (CBCT) to verify or
align the patient on the IMRT bed. The treatment volume (CBCT) is often registered to
the simulation volume (CT) to determine the appropriate daily treatment couch shifts.
The registered volumes allow the radiation oncology team to position the patient as close
as possible to the simulated treatment orientation. One problem with CBCT is that the
imaging procedure is done right before treatment delivery, thus it cannot monitor patient
and organ motion during treatment to determine if the target has moved out of the
treatment field.
Ultrasound (US) offers an attractive alternative to CBCT for imaging IGRT
targets in the abdomen, such as the bladder. US-based guidance systems can provide
intrafractional motion with high spatial and temporal resolution. The
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purpose of this chapter is to define the physics that provides contrast when imaging with
US and the transducer properties contributing to resolution limits. Next, the US field of
view (FOV) will be characterized to determine the optimal settings with regard to
imaging depth, focal region, with and without harmonic imaging, and artifact
identification. Defining the optimal imaging parameters will allow us to determine the
minimum errors expected when registering multimodal volumes.

3.2 Ultrasound Imaging

3.2.1 Wave propagation
Mechanical energy transmits through a continuous, elastic medium by the
compression and rarefaction of “particles” that comprise it20. The waves travel at a speed
of sound c, given by,

𝑐=√

1
κρ

Where κ is the compressibility and ρ is the density of the material.

(3.1)
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Figure 3.1 Ultrasound wave propagation. Ultrasound energy is generated by a
mechanical displacement in compressible medium. Energy propagation is shown as a
function of time, resulting in areas of compression and rarefaction with corresponding
variations in positive and negative pressure amplitude.
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The waves are three-dimensional and dependent on time. Independent of the
physical measures used to describe sound waves, they must depend on three variables in
the spatial domain, x, y and z, and time, t21. The particles are displaced from equilibrium
by a displacement amplitude, u(x, y, z, t), and at a particle velocity, v(x, y, z, t)), as the
wave disturbance passes through the medium. This change also corresponds to a local
pressure disturbance, p(x, y, z, t), that must satisfy the three-dimensional wave equation,
(

𝜕2
𝜕2
𝜕2
1 𝜕 2 𝑝(𝑥, 𝑦, 𝑧, 𝑡)
+
+
)
𝑝(𝑥,
𝑦,
𝑧,
𝑡)
=
𝜕𝑥 2 𝜕𝑦 2 𝜕𝑧 2
𝑐2
𝜕𝑡 2

(3.2)

If we assume a plane wave traveling in the z-direction, the wave equation reduces to,
𝜕 2 𝑝(𝑧, 𝑡)
1 𝜕 2 𝑝(𝑧, 𝑡)
=
𝜕𝑧 2
𝑐 2 𝜕𝑡 2

(3.3)

with the solution to the particle’s position at any given time,
𝑢(𝑧, 𝑡) = Asin(𝑘𝑧 − 𝜔𝑡)

(3.4)
𝜔

where A is the maximum displacement, k is defined as the wavenumber, 𝑘 = , and ω is
𝑐

the angular frequency, 𝜔 = 2𝜋𝑓.
The driving force of a wave in matter is the pressure and the particle velocity22.
Therefore, the characteristics of a sound wave relates to the properties of the medium in
which it is propagating by the acoustic impedance, Z, which is the ratio of the pressure to
particle velocity22.
𝑝(𝑧, 𝑡)
𝑣(𝑧, 𝑡)

(3.5)

1 𝜕𝑠
1 𝜕[𝐴𝑠𝑖𝑛(𝑘𝑧 − 𝜔𝑡)]
1
=−
= − 𝐴𝑘𝑐𝑜𝑠(𝑘𝑥 − 𝜔𝑡)
𝜅 𝜕𝑧
𝜅
𝜕𝑧
𝜅

(3.6)

𝑍≡

where,
𝑝(𝑧, 𝑡) = −
and,
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𝑣(𝑧, 𝑡) =

𝜕𝑢 𝜕[𝐴𝑠𝑖𝑛(𝑘𝑧 − 𝜔𝑡)]
=
= −𝐴𝜔cos(𝑘𝑧 − 𝜔𝑡)
𝜕𝑡
𝜕𝑡

(3.7)

Therefore,

𝑍=

1
− 𝜅 𝐴𝑘𝑐𝑜𝑠(𝑘𝑥 − 𝜔𝑡)

(3.8)

−𝐴𝜔cos(𝑘𝑧 − 𝜔𝑡)

where the relationships,
𝜅=

1
𝜔
,𝑘 =
2
𝜌𝑐
𝑐

(3.9)

can be used to reduce Z to,
𝑍 = 𝜌𝑐

(3.10)

3.2.2 Interactions with Matter
As the pressure waves travel through the medium, they experience a number of
interactions, where the primary interaction resulting in US contrast is the scattering
properties. If the boundary is large compared to the wavelength, specular reflections
dominate, where the transmitted portion of the wave will bend or refract as the angle of
incident of the acoustic wave relative to the boundary deviates from being perpendicular.
Non-specular acoustic scattering arises from objects that are the size of the wavelength or
smaller, resulting in diffuse reflections
If a perpendicular wave travels from a material of acoustic impedance, Z1, to a
material of acoustic impedance, Z2, a fraction of the sound intensity is reflected. The
reflection coefficient, RI, describes the ratio of the intensity of the wave that is reflected
to the intensity of the incident wave.
𝑍2 − 𝑍1 2
𝑅𝐼 = (
)
𝑍2 + 𝑍1

(3.11)
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The fraction that is transmitted is,
𝑇𝐼 = 1 − 𝑅𝐼

(3.12)

If the wave is not normal to the boundary, the transmitted wave bends according to
Snell’s Law,
sin(𝜃𝑡 ) 𝑐2
= ,
sin(𝜃𝑖 ) 𝑐1

(3.13)
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Figure 3.2 Ultrasound interactions with matter. A) Reflection and refraction of
ultrasound occur at tissue boundaries with difference in acoustic impedance, Z. From left
to right: Perpendicular incidence (90 degrees), non-perpendicular incidence (c2 > c1),
non-perpendicular incidence (c2 < c1). B) Specular scattering (left), Constructive and
destructive interference of scattered waves (right).
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3.2.3 Beam Formation
Ultrasound waves are produced and detected with a transducer, comprised of one
or more ceramic elements (piezoelectric) with electromechanical properties and
peripheral components20. When voltage is applied to the elements, the crystals change
their structure, causing the elements to expand and contract. This physical deformation
converts electrical energy into mechanical energy, generating sound waves. Inversely,
mechanical pressure administered to the surface of the crystal produces electrical energy.
Transducers used for standard pulse-echo ultrasound imaging operate in a “resonance”
mode, whereby a short voltage pulse is applied, triggering the piezoelectric element to
contract and then vibrate at a natural resonance frequency20. A damping block is
positioned on the back of the piezoelectric element, to produce an ultrasound pulse with a
short spatial pulse length (SPL). Dampening of the vibration introduces a broadband
frequency spectrum. The “Q factor” describes the bandwidth of the sound emanating
from the transducer as
𝑄=

𝑓0
𝐵𝑎𝑛𝑑𝑤𝑖𝑑𝑡ℎ

(3.14)

A narrow bandwidth and long SPL are observed in” high Q” transducers whereas wide
bandwidths and short SPLs are the result of “low Q” transducers20.

3.2.4 Resolution
As the ultrasound beam propagates from the transducer surface into the medium,
it displays two unique beam patterns. The near field is before a distance determined by
the geometry and frequency of the transducer where the beam converges. Beam
convergence in the near field happens because of various constructive and destructive
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interference patterns of the waves produced from the transducer surface. The beam
diverges in the Fraunhofer (far field) zone and in contrast to the near field, intensity
decreases with distance.
The ability of an US system to discern two objects in space, the axial and lateral
resolution, is primarily dependent on the transducer properties. The axial resolution is
along the direction of the beam and is independent of depth. The SPL limits the axial
resolution. Reflectors that are separated by a distance greater than ½ the SPL produce
echoes from the first object that are completely distinct from echoes reflected from the
second object, whereas boundaries with less than ½ the SPL result in returning echoes not
being able to be resolved20. Higher frequencies reduce the SPL and thus improve the
axial resolution. Lateral resolution is defined as the capability to distinguish two separate
objects in close proximity perpendicular to the beam direction. Lateral resolution depends
on depth, beam frequency and scan line density23. The highest lateral resolution is found
at the focal distance and adequate in the focal zone.

3.2.5 Artifacts
Image quality is dependent on the design characteristics of the ultrasound
equipment, the numerous equipment variables selected, and positioning skills of the
operator. Image quality is measured by spatial resolution, contrast to noise and image
uniformity. Image artifacts are common in ultrasound and often degrade image quality,
although on occasion they can be used to enhance diagnostic integrity. Artifacts are the
inaccurate display of anatomy during image acquisition. The causes are variations in
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operator technique, machine degradation or simply inherent to ultrasound interaction with
tissues.
Common artifacts include reverberation, refraction, shading and enhancement,
speed displacement, and speckle. Reverberation appears as the inaccurate display of
tissues due to signals being reflected back and forth between two closely spaced objects
or interfaces24. Refraction is a change in the longitudinally transmitted ultrasound
direction at a boundary where the angle of incidence deviates from being perpendicular
between two tissues with differing speed-of-sounds (seen in Figure 3.2). Shadowing is a
weak signal beyond an object or interface. It is caused by objects with high attenuation
coefficients or reflection from large Z differences of the incident beam. Enhancement
occurs beyond objects having low attenuation, for example, fluid-filled cavities (e.g.
bladder). Hyperintense signals return the transducer not proportional to the assumed
transmission through these structures. Speed of sound displacement is produced by the
variations of speed of sound in different tissues. All of the factors contribute to image
distortion and blurring of the target boundaries.
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3.3 Methods

3.3.1 Imaging Protocols
B-mode ultrasonography of all phantoms was performed with a dedicated
ultrasonography machine (Philips iU22 SonoCT system, Philips Ultrasound, Bothell,
WA). A broadband volume curved array transducer (6-2 MHz) was utilized.
The Computerized Imaging Reference Systems (CIRS, Norfolk, VA) Model
040GSE Multi-Purpose, Multi-Tissue Ultrasound Phantom was used for characterizing
the field of view for different imaging parameters. The phantom includes a group of wire
targets that appear as bright dots or lines (depending on the orientation of the transducer)
in the image. These targets are made from nylon monofilimanet with diameter of 0.8 and
1.0 mm and have an attenuation of 0.5dB. The different target groups utilized in this
experiment are shown in Table 3.1.
We imaged the phantom with a maximum depth of 16, 10 and 5 cm and a focal
region in the top third, middle third and bottom third for the 16 and 10 cm depths. Only
one focal region was used for the 5 cm depth procedure. Volumes were recorded with and
without harmonic imaging for each procedure, resulting in 14 independent scans. Images
were optimized with the use of the i-scan function (automatically compensate for gain)
prior to each recording. Voxel size was only dependent on the depth and irrespective of
the focal depth, with or without harmonic imaging or the use of the i-scan function.
Voxel sizes can be seen in Table 3.2.
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Table 3.1. Phantom target characteristics
Wire Targets
Material
Nylon monofilament
Vertical
Horizontal
Distance Group Distance Groups
Number of targets

16

6&7

Diameter

100 µm

100 µm

Depth Range
Distance between
targets

1 -16 cm

4 & 9 cm

10 mm

10 & 20 mm

Table 3.2. Volumes and voxel sizes for the corresponding imaging
depth
Voxel Size
Depth
Volume Dimensions
[Axial/Lateral/Elevational]
[cm]
[row/col/slice]
[mm]
16

512/510/256

0.463/0.337/0.670

10

512/510/256

0.336/0.219/0.450

5

512/463/256

0.229/0.132/0.269
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3.3.2 Phantom Analysis
The full width half max (FWHM) of each wire was calculated for each depth,
focal region, and with and without harmonic imaging. The average and standard
deviation of the FWHM were calculated for each focal region of the corresponding image
with respect to maximum depth of the image and with and without harmonic imaging.
First, the axial and lateral resolution within the one focal region of the 5 cm depth image
was determined as a function of depth and horizontal position. Next, the axial and lateral
resolution was analyzed with the focus in the near, mid and far fields. This data was used
to determine the optimal imaging procedure. Lastly, the FWHM and voxel sizes under
ideal conditions were compared to that of CT and CBCT to determine the minimum
statistical error associated with multimodal volume registrations.

3.3.3 Artifact Analysis
A series of Transitional Cell Carcinoma (TCC) cases presented to the Purdue
University Veterinary Teaching Hospital were examined for artifacts. The images were
recorded with diagnostic intent and consequently should have minimal artifacts.
Therefore, any artifacts present can be assumed to also be present in a scenario where US
is used solely for patient positioning, where the purpose of the procedure is not to
diagnose disease but simply to identify the margins and boundaries of critical organs.
Any artifacts present shall be quantified and included in error analysis to determine the
minimum statistical error associated with multimodal volume registrations.
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3.4 Results

3.4.1 Phantom
The US QA phantom was imaged under 14 unique conditions, which depended on
the maximum depth of the scan, focal region, and with and without harmonics. The
FWHM of 100 µm nylon wires was used to determine both the axial and lateral
resolution throughout the FOV.
The initial scan, shown in Figure 3.3, was with a maximum depth of 5 cm and
used only one focal region. We saw no change in axial resolution as a function of depth
within the focal region. In addition, we saw no change in lateral resolution as function of
horizontal position. The axial FWHM was significantly lower (p = 0.000545) in the
harmonic image (1.88 ± 0.16 mm) than that of the original (2.78 ± 0.22 mm). The lateral
FWHM was significantly higher (p = 0.0212) in the harmonic image (1.55 ± 0.18 mm)
than that of the original (1.29 ± 0.15 mm).
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Figure 3.3 Axial and lateral FWHM analysis (5 cm). A) 5 cm depth image (left) and
harmonic (right). B) Axial (top) and lateral (bottom) signals for the original (left) and
harmonic (right) images. C) Full width half max plots. **P<0.001 *P<0.05
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The subsequent scans, shown in Figure 3.5 and Figure 3.6, were with a maximum
depth of 10 and 16 cm and utilized three focal regions (near field, mid field and far field).
There was no significant difference in axial and lateral FWHM as a function of focal
region. The harmonic scan yielded a significantly lower axial FWHM than the original in
the mid and far region of the 10 cm depth scan. In addition, the harmonic images had a
significantly lower FWHM for the wires at a depth of 4 cm and a mid-field focal region
and the wires at a depth of 9 cm and the far field focal region than the original scans. The
axial resolution and lateral resolution for harmonic imaging at a maximum depth of 16
cm ranged from 1.90 - 1.91 mm and 1.58 – 1.92 mm, respectively, compared to 2.13 2.36 mm and 1.58 – 1.82 mm for the axial and lateral resolution, respectively, for the 10
cm depth.
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Figure 3.4 Images at 10 cm depth. A) near field, B) mid field and C) far field focal region without harmonic imaging. D) Near field,
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E) mid field and C) far field with harmonic imaging. Arrows point to the vertical and horizontal wire groups.
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Figure 3.5 Images at 16 cm depth A) near field, B) mid field and C) far field focal region without harmonic imaging. D) Near field, E)
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mid field and F) far field with harmonic imaging. Arrows point to the vertical and horizontal wire groups.
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Figure 3.6 Axial and lateral FWHM analysis (10 and 16 cm). Average ± SD axial and
lateral (4 and 9cm) FWHM of original and harmonic scans at three different focal regions
for the maximum imaging depth of 10 cm (A) and 16 cm (B).
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3.4.2 Artifacts
We retrospectively examined a series of TCC cases presented to the Purdue
University Veterinary Teaching Hospital for image quality, focusing on artifacts. An
example of the artifacts we identified can be seen in Figure 3.7. Rarely did comet-tail
artifacts, caused by reverberation, extend into the bladder. Reverberation had the
potential to blur the most anterior edge of the bladder closest to the skin and abdominal
muscles, but were infrequent, small in size (1 mm) and easily identified. The combination
of these features made it easy to predict where the bladder wall should be. Refractive
artifacts, caused by non-perpendicular incidence of the ultrasound beam to the bladder
wall, are seen as discontinuities in the bladder wall where the beam is reflected away
from a particular point and there is no signal. This artifact can cause the bladder wall to
“disappear,” but it was typically localized and there was enough information to not
interfere with accurate contouring.
Refraction, when combined with displacement artifacts caused by variations in
the speed-of-sound due to tissue heterogeneities, resulted in severe discontinuities in the
distal edge of the bladder wall. The largest refractive index would be caused from the
beam travelling from fat (1412 m/s) to tumor (1584 m/s). By applying Snell’s law, we
can calculate the largest difference between the incident angle and the transmitted angle.
In this case, when the incident angle is 64° the transmitted angle will be 85°. The
relationship between incident and transmitted angle for this extreme case is shown in
Figure 3.8A. An example of a similar case (tumor to urine) can be seen in Figure 3.8B,
where the shape of the tumor causes a large incident angle, bending the beam away from
the bladder wall and increasing the true path length.
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Two separate path lengths are shown in Figure 3.9. If we consider a saline
solution with density near that of urine, 1.05 g/L25 and at body temperature, the speed of
sound will be approximately 1554 m/s26. Similarly, the speed of sound in cancerous
tissue is approximately 1584 m/s27. Therefore, the true distances to the distal edge of the
bladder for the two path lengths shown cause the centroid of the bladder (and tumor) to
be misrepresented, changing the absolute position of the bladder, causing the patient to be
misaligned during treatment. The centroid of the bladder could move up to 2.5 mm based
on contours of the bladder for different interpretations of the distal bladder edge.
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A

B

Figure 3.7 Ultrasound TCC image. A) Highlighting good bladder and tumor contrast. B)
Highlighting reverberation (C), refraction (D) and speed of sound displacement (E).
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Figure 3.8 Refractive artifact. Extreme case of refraction (red) causing discontinuities in
the distal bladder wall. Paths on the left and far right are fairly perpendicular.
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Figure 3.9 Speed of sound displacement artifact. Bladder centroid location based on
three contours representing different interpretations of the distal bladder edge.
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3.5 Discussion
Independent measurements of image quality of 3D-US were compared to
determine an optimal set of acquisition protocols, where depth, focal region and harmonic
imaging were controlled. The effects of these parameters on uniformity of spatial
resolution were studied. Furthermore, a series of images were examined for the presence
of artifacts that may degrade image quality. The central result from this study is that only
the use of harmonic imaging had a significant effect on spatial resolution and that spatial
resolution was not dependent on the FOV or the focal region. Few artifacts were present
within the bladder. Of them, only discontinuities on the distal edge of the bladder were
consistent. The results from Figure 3.8 demonstrate a possible 2.5 mm shift in the
centroid of the bladder.
For most imaging systems, line pairs per millimeter or centimeter is a more
common method for describing the limiting spatial resolution than FWHM. Line pairs per
millimeter can be converted to FWHM ~ 1/(2 x LSF). Therefore, a FWHM of
approximately 2mm, which closely represents our 6-2MHz broadband transducer,
corresponds to 0.25 lp/mm or 2.5 lp/cm. This is considerably worse than kV-CBCT
systems, but better than MV-CBCT systems, which report a range of 8-11 and 3-5 lp/cm
respectively28. The use of MV-CBCT systems has been demonstrated, and often superior
when compared to US for localization of the prostate29,30. These findings are
counterintuitive when considering US yields comparable resolution. The comparable
spatial resolutions between US and MV-CBCT and accuracy of patient alignment lead to
the belief that other factors are diminishing the accuracy of US systems.
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One possible explanation is the heterogeneity of the speed of sound in soft tissue.
Distances in US are calculated using the time of flight of the reflected US pulse assuming
a constant speed of sound of 1540 m/s in soft tissue. Recently, speed of sound correction
algorithms for 3D linear31 and curvilinear32 probes have been published. These studies
show corrections for prostate imaging can be greater than 4 mm. A second explanation
could be the imaging procedure, specifically distortions caused by probe pressure. Many
of the initial US based IGRT systems used free-hand imaging procedures, which could
lead to inconsistent image acquisition. The only study to date, investigating the impact of
probe pressure on image distortion and trying to recreate the distortions using pressure
sensors yielded poorer results33. None of the systems appear to be trying to remove the
pressure distortions through the use of a coupling medium.

3.6 Conclusions
In conclusion, the inherent resolution of 3D-US is high enough to expect
alignment errors on the order of MV-CBCT. Many of the underlying physical principles
of US had very little effect on the resolution of our imaging system. We observed similar
resolutions whether imaging at a depth of 5, 10 or 16 cm. In addition, there was no
significant change in resolution as a function of depth or whether the targets were in the
focal zone in each of the subsequent scans. On the other hand, harmonic imaging showed
significantly better resolution in both the axial and lateral directions when imaging at a
maximum field of view depth of 10 and 16 cm. Speed of sound discontinuities of the
distal bladder edge were the most visible of any of the common artifacts associated with

37

US imaging. The integration of already developed correction algorithms should be
applied to future clinical studies.
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CHAPTER 4. CONSTRUCTION OF AN ULTRASOUND GUIDANCE PLATFORM
FOR IMAGE-GUIDED RADIOTHERAPY WITH THE INTENT TO TREAT
TRANSITIONAL CELL CARCINOMA

4.1 Introduction
A number of US external beam radiation therapy (EBRT) guidance systems have
been developed in recent years34-36. A detailed review of these systems both
commercially available and in-house systems still under development has been
published37. Though each system has its advantages and disadvantages, their
shortcomings are: 1) transducer pressure distorts patient anatomy and since the transducer
is not present during the simulation CT (artifacts), the US and CT volumes do not
represent the same information and introduce significant systematic positioning errors; 2)
free-hand image acquisition is highly dependent on the skill of the operator and
subsequently the positional information is operator dependent; 3) free-hand probe
manipulation systems can’t provide intrafractional imaging because the operator would
be exposed to unacceptable levels of radiation during treatment delivery.
Our objective is to demonstrate that daily 3D transabdominal US will provide
accurate bladder tracking to include RT in the treatment of canine TCC. An US platform
has been constructed and integrated into the treatment protocol in order to track the
bladder of a canine patient while overcoming the previously
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mentioned deficiencies. The objective is to determine the CT and US alignment errors
within a few millimeters, which is better than or equal to CBCT. In this specific aim, the
design and construction of an in-house integrated US manipulator and platform is
described. To validate the US-platform, an agar-based urological tissue phantom was
fabricated and used to quantify alignment errors based on rigid-body image registration in
Eclipse treatment planning system. The goal is to provide a treatment procedure without
the need for on-board radiographic imaging devices.

4.2 Materials and Methods

4.2.1 Construction of 3D-US platform
This platform provides a common coordinate system between CT and RT, and it
serves two purposes. First, the platform provides an adaptable manipulator with
reproducible positions, with error less than positional error of IMRT bed, to adapt to the
patient on the CT and IMRT beds. Second, it also provides enough adaptability to align
the patients so the initial conditions to the co-registration algorithm within treatment
planning software converge to an optimal alignment. The US-platform defines a
coordinate system based on 3D ultrasonic images that will determine the translation and
rotation matrix between the CT scanner coordinate system, the 3D-US imaging system,
and the IMRT coordinate system. The critical aspects of the platform are to 1) place and
locate the transducer array with submillimeter precision, 2) change the angle of the
transducer array to provide a means to optimize image quality, 3) assemble and
disassemble quickly and easily around the patient on the CT/RT couch and 4) be
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constructed out of materials that will not affect RT planning. Acrylic was used for the
supports due to its low cost and speed with which it can be manufactured. The parts that
could not be manufactured were 3D printed using Purdue’s 3D-printing facilities. All the
manufacturing was done in Purdue’s Artisan and Fabrication Lab. The final design can be
seen in Figure 4.1.
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Figure 4.1 Platform design overview. A) Overview of the platform design, B)
Longitudinal and lateral range, C) Different possible discrete angles of the transducer, D)
different coordinate systems of the US guidance platform and the RT treatment bed.
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The frame can be assembled around the patient after the patient is positioned
using laser alignment. After a series of proof of concept examinations with a continuous
geometry, the decision to have discrete positions would simplify setup and reduce interuser error when trying to read angles and distances. A set of “slots” for the translating
stage to rest were designed to be 5 cm apart laterally from the center, and a limited set of
angles in 15° increments from which to set the transducer array position. This increased
the speed with which the images could be acquired without compromising range of
motion The extension of the radial arm and the longitudinal shifts are done with a 1mm
threaded rod which gives us increments as fine as 10 microns.
A critical step in the US-platform design was a clamp or mold to hold and
position the transducer array with high reproducibility, thus defining the central axis of
the transducer array within the platform’s geometry, thus relating the coordinate systems
of the linear accelerator and CT bed. Three different transducer arrays were utilized
throughout this study: an Acuson 8-5 2D linear array,a Philips V13-5 3D linear array, and
a V6-2 3D curvilinear array. Each individual transducer array surface was modeled using
a 3D infrared scanner, borrowed from the Purdue Artisan and Fabrication Lab. The
transducers were positioned on a black surface with the directional marker on the side.
This was because the transducers are mirrored about that plane. Therefore, we only
needed to scan half of the transducer and the other half was modeled in CatiaTM (Dassault
Systémes, Walthman, MA, US). Reflective stickers provided by the 3D scanner were
placed on and around each of the transducer arrays, scans were acquired, and files were
exported in the STereoLithography (stl) format and imported into the CatiaTM
environment for rendering. Once the designs were completed, the model for each
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transducer array was 3D printed using a filament based thermoplastic (PLA, ρ = 1.25
g/cm3) to be used as a CT safe placeholder transducer. With these same surface
renderings, clamps were designed to form-fit each transducer. Individual clamps are
interchangeable with the platform.
We calibrated the US-platform to the coordinate system of the linear accelerator
by first selecting an “origin”, where one of the discrete positions on the platform was
chosen and the x, y, and z coordinates of the treatment couch recorded. To determine the
precision, we defined discrete positions of the TA within the platform, used the geometry
to predict the new coordinates of the couch and then moved the couch to determine the
error using an in-house MATLABTM (The MathWorks, Inc., Natick, MA) graphical user
interface (GUI).

4.2.2 Developing a Urological Phantom of the Bladder
To incorporate the US-platform into the treatment planning protocol, a soft tissue
phantom was fabricated with the acoustic and CT properties consistent for a patient with
bladder cancer, in this case a dog with TCC. The phantom was constructed based on the
anatomy obtained from CT and US scans of a dog, tissue types and geometric dimensions
(see Figure 3.7 and 3.8). This phantom was molded in a 12 x 12 x 12 cm acrylic
container, with a 3 mm layer of skin, 1 cm layer of fat, 1 cm layer of muscle, and 25 mL
ellipsoid (balloon) of 5% NaI saline (urine), embedded within a 7 cm layer of soft tissue.
The CT and 3D US images of the bladder phantom are displayed in Figure 4.2. The
phantom is a mixture of agar, glycerin and physiological saline, where the proportion of
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each element is chosen to control the density and speed-of-sound consistent with skin,
muscle, soft tissue and bladder.

Figure 4.2 Phantom. A) CT slice of phantom, B) corresponding US slice
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The solutions were brought to a boil in a microwave and then stirred constantly
while they came down in temperature. When the solution reached 40oC they were
transferred to the phantom. At this temperature the solution would turn to gel quickly
when left undisturbed. This consistently produced mediums with the most uniform set of
acoustic and CT properties and minimal air bubbles. The balloon was suspended within
the plexiglass container of the phantom by running a suture through the balloon, just
above the knot. The soft tissue agar solution was poured to cover the balloon. When the
solution was set, the suture was pulled through and removed. Saran wrap was used
between mediums to keep the glycerin from leeching out. A flat edged block was used to
push any air bubbles that formed between the wrap and the agar to the edges. A final
layer of saran wrap was placed on top as a seal. By evaluating the CT and US images,
we found that the physical properties of the phantom remained consistent for about 3
weeks when stored at room temperature.
To determine the density and speed-of-sound of the different tissue types of the
phantom, CT and photoacoustic was used. For the former, the average value of
Hounsfield units for each tissue type using CT was calculated, and then converted to
density based on the calibration curve obtained from a QA CT phantom (Gammex 464
ACR CT Phantom). To determine the speed of sound, photoacoustics methods were
employed. A point source, fishing line with one end dipped in india ink, was placed at the
bottom of beaker. This absorber was exposed to a laser source and the resultant
photoacoustic signal was measured using an ultrasound transducer at two distances 1 cm
apart. The time at which the peak signal was measured at both transducer locations was
used to calculate the speed-of-sound for each tissue type. To validate this technique, the
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speed-of-sound for distilled water at temperatures ranging from 4°C to 50°C was
measured and compared to the literature (Figure 4.3). This same method was used to
determine the speed of sound of different concentrations of distilled-H2O (dH20) and
glycerin, assuming the speed of sound for a mixture of dH2O and glycerin followed a
linear model. For example, water at 25°C has a speed of sound of 1494m/s and pure
glycerin travels at 1920m/s. Thus,
𝑚
𝑚
𝑚
𝐶50/50 = 0.5 ∗ 1920 [ ] + 0.5 ∗ 1494 [ ] = 1707 [ ]
𝑠
𝑠
𝑠

(4.1)

We measured distilled water and 2% agar to determine if the agar was affecting the speed
of sound.
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Figure 4.3 Photoacoustic validation of the speed of sound in water. A) Sample
photoacoustic signals showing the speed of sound differences as a function of
temperature. B) Measured data and function fit to the literature values.
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4.2.3 Imaging Protocols
B-mode ultrasonography of all phantoms was performed with a dedicated
ultrasonography machine (Philips iU22 SonoCT system, Philips Ultrasound, Bothell,
WA). A broadband volume curved array transducer (6-2 MHz) and/or a broadband
volume linear array transducer (13-5 MHz) were utilized. The depth, focal spot and
window level were adjusted to optimize image quality, resulting in a 512 x 510 matrix
with a 0.42 x 0.30 x 0.6 mm voxel size (see Specific Aim 1). The probes were positioned
in a transverse plane for all imaging studies. All phantoms were scanned using a 64-slice
helical CT scanner (GE Lightspeed 64 Slice CT Milwaukee, WI, USA) using the
following parameters: kVp of 120, mA of 300-500, slice thickness of 2.5 mm, pitch of
1.0, variable scan field of view, 512 x 512 matrix, rotation time of 1 s. Resulting in a 0.54
x 0.54 x 2.5 mm voxel size.

4.2.4 Image Registration
The volumes need to be co-registered with the CT scans used in the IMRT
treatment planning software in order to be used as a method for patient positioning. We
wanted to do all the registrations in Eclipse Treatment Planning system. In order for
Eclipse to recognize the US images, a MATLABTM script was developed to create dicom
files for the 3D-US volumes, which were exported from the US unit’s hard drive to a
removable media device and then loaded into MATLABTM through a dedicated folder.
We separated the metadata (dicom headers) from a CT slice, stripped the header
information and saved the file as a CT template. The template with dicom data pulled
from the US volumes. Unlike CT where each slice stands on its own, the US volumes are
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exported from the unit as one 3D matrix. We used a script to separate each slice from the
exported volume, assign new metadata with the correct positional (couch and platform
coordinates) and voxel information and write new dicom images. The files could then be
imported into Eclipse using the dicom media file import filter as if they were CT scans.
When a patient, canine, human, or urological phantom, is moved from the CT
scanner to the RT suite, the patient and 3D-US platform is repositioned on the treatment
couch at nearly the same position through the use of PinnPoint Lok-BarTM (CIVCO
Medical Solutions, France) and laser alignment. An US volumetric image is acquired and
processed using the previously mentioned methods, and co-registered to the treatment
planning CT images within Eclipse. The transformation matrix is used to modify the RT
treatment bed to match CT and RT coordinate systems. Critical to this protocol is the
ability to accurately and precisely co-register either the treatment US volume to the
simulation US/CT volume. To measure these parameters, the bladder phantom was
translated and rotated relative to the US transducer array. The experimental setup for
these tests is shown in Figure 4. For each measurement, the phantom was rotated (using a
rotating platform) over a 0-45 degree range -- at angles rotated 5, 15, 30 and 45o around
the vertical axis -- and the transducer was translated over a 0-20 mm range in different
increments, after which a CT and US scan was acquired. This procedure was repeated
after inserting a 4° wedge to change the patient pitch.
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Figure 4.4 Experimental design. A) Picture of the phantom and platform in the CT
scanner with the placeholder transducer in place. B) Components involved in the
experimental design
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Each subsequent scan was co-registered to the scan taken with the phantom in the
flat position (and a wedge angle of zero). The registration matrices composing of the x, y
and z translation and , , and  rotational components (Euler angles) were recorded. For
the US scans, the transducer array was held in a clamp above the phantom and the
experiment was repeated three times for each set of rotation angles (N=3). The US and
CT volumes were co-registered using the software in Eclipse, which will be compared to
the CT-CT co-registration. For each registration, the first modality is the source volume
and the second is the target volume.

Figure 4.5 Volume Registrations. A-C) US-CT registration for phantom in the ‘flat’ position. The pre-registered volumes can be seen
in (A), the same window in color in (B) and the registered volumes in (C). Transformation matrices for each rotation can be found in
Table 3. D-F) CT-CT registration between the phantom rotated to 45o and the flat position. G-I) US-CT registration between the
phantom rotated to 45o and the flat position. J-L) US-US registration between the phantom rotated to 45o and the flat position. The
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transformation matrices for D-F, G-I and J-L can be found in Table 4.4.
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Our standard method for co-registration included, first assuming no a priori
knowledge. We made no manual movements or changes to the image before attempting
an automatic registration. The details powering the EclipseTM automatic registration are
proprietary, but the underlying merit function is based on mutual information. If by visual
inspection the automatic registration failed, then a rough manual match was applied. If
the automatic registration still failed, then the field of view was modified to include only
the “tissue,” then only the skin, muscle and bladder and lastly, only the bladder. Lastly,
image intensity thresholds were adjusted if all else failed. All US-to-US and CT-to-CT
registrations could be successfully automatically registered whereas the US-to-CT
registrations were done manually.

4.3 Results

4.3.1 Construction of 3D-US platform
The purpose of the US-platform was to reduce uncertainty in patient positioning
prior to IMRT. Therefore, the ability of our platform to be calibrated to the coordinate
system of the linear accelerator was critical in our final evaluation. During initial testing,
a systematic error stemming from the platform not being square to the treatment room
lasers was identified. Over the lateral range of the RT couch, the longitudinal and vertical
offsets were 2mm and 1mm respectively. These offsets were viewed using the room
lasers and in the image registration. To evaluate patient realignment uncertainty, the arm
of the platform that holds the transducer array (TA) was positioned at the treatment room
iso-center and then the TA was rotated through each discrete angle at which the central
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ray normal to the TA surface. This process was repeated and the average and standard
error calculated. The errors between what we calculated based on the geometry of the
platform and the true couch readings are shown in Table 4.1 with a diagram of the
experiment in Figure 4.2
The platform design provides a reproducible coordinate system for US volumes to
be registered to CT for patient positioning in the RT suite. The acrylic supports caused
light streaking artifacts and could be avoided completely by selecting a field-of-view that
avoids the supports. Although PLA has a higher density than acrylic, the use of a
honeycomb infill pattern reduces the overall density of the printed parts and further
reduced streaking artifacts. We attempted a handful of prints using the thermoplastic
Acrylonitrile Butadiene Styrene (ABS) because of its lower density and effective Z than
PLA, but we found ABS to be much more difficult to work with and produce parts of
good enough quality to be used. Further studies developing optimal printer settings would
be beneficial to groups looking to use 3D printed parts in radiology and RT.

Figure 4.6 X shows the lateral shift, Y shows the vertical shift and the longitudinal shift is in and out of the page.
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Table 4.1 Errors between predicted couch position and actual couch position [mm] for
moving the transducer from 75° to 60°, 60° to 45°, etc.
Average
75 → 60
60 → 45
45→30
30 → 15
-0.00 ± 0.99
-0.22 ± 0.9
0.13 ± 0.89 -0.16 ± 1.28 0.25 ± 1.11
vrt
0.10 ± 0.72
-0.20 ± 0.84
-0.20 ± 0.84 0.60 ± 0.55 0.20 ± 0.45
lng
0.18 ± 0.85
0.46 ± 1.29
0.03 ± 0.81 0.18 ± 0.83 0.06 ± 0.55
lat
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4.3.2 Developing urological phantom of the bladder
Results for the density and speed-of-sound measurements are shown in Figure
4.7. In Table 4.2, the recipe for constructing agar-based tissue phantoms with the
necessary density and speed-of-sound consistent with skin, muscle, fat and the bladder
and their corresponding values as measured by CT and US is displayed. Tissue phantom
density was measured using CT, where the relationship between density and Hounsfield
units was measured using the Gammex 464 CT Phantom and the calibration equation
(Figure 4.7(A))
𝑦 = .001𝑥 + .9939.

(4.2)

The linear model assumed in equation 5.1 fit the data with an R2 = 0.972 for the speed of
sound with a range of concentrations of glycerin. Agar increased the speed of sound
compared to dH2O from 1497 to 1506 m/s at 25°C. The speed of sound for cooked agar
and dH2O can be seen in Figure 4.7(C).
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Figure 4.7 Phantom density and speed of sound validation. A) CT QA phantom
calibration. From left to right: air, polyethylene, water, acrylic, bone. B) Measured speed
of sound as a function of glycerin concentration compared to predicted values from
equation 1. C) Measured speed of sound of 2% agar as a function of temperature. Solid
line indicates the accepted speed of sound of water.

Table 4.2 Recipe for phantom with measured CT number [HU], density [g/cm3] and speed of sound [m/s]
with corresponding values found in the literature
Recipe
Measured
Literature
Speed of
Speed of
%
%
CT Number
Density**
Density
Sound
Sound
Glycerine Agar
1493
148339
Water
0
0
-1.21 ± 2.64
0.99838
0.993
1703*
1590-217040
Skin
50
2
107.34 ± 3.49
1.110 - 1.11925
1.098
1487*
1412 - 148741
Fat
0
2
2.66 ± 2.67
0.91625
0.996
1595*
1589 - 160341
Muscle
25
2
69.65 ± 3.91
1.038-1.05625
1.061
-155426
Urine
0
0
41.51 ± 0.87
1.001-1.05025
1.034
Phantom measured at room temperature. *Calculated from equation (4.1). **Calculated from equation
(4.2). Literature speed of sound measurements mostly from canine tissue. Literature density values from
human tissue.
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4.3.3 Image Registration
First, we examined the ability of our processing methods to successfully import
US volumes into EclipseTM (Varian Medican Systems INC., Palo Alto, CA.). The US
volumes could not be imported into Eclipse when sent through PACS, either via the
import wizard or the DICOM import/export window. This was due to the DICOM
headers for CT and US data being different. To resolve this mismatch in format, a CT file
was used as a template, where the header parameters SliceThickness, PixelSpacing,
InstanceNumber, ImagePatientPosition and PatientPosition were redefined based on US
imaging protocols. Caution needs to be taken when setting the x, y and z resolution as
they were very dependent on the settings of the US unit at the time of the volume
acquisition. For example, the field-of-view had a direct effect on the voxel sizes.
Validation of the voxel size assignment is shown in Figure 4.8. The lateral phantom
width was measured in CT (12.03 cm) and US (12.35 cm) for an error of 3.2 mm.
Additionally, we measured the distance from the surface of the skin layer to the bottom of
the phantom in both CT (8.89 cm) and US (9.05 cm) for an error of 1.6 mm. Although,
the z-position, or slice location, could easily be defined with a simple calibration, the x
and y positions are dependent on where the target is in the image in relation to CT and
thus needed to be registered to the CT to be known. However, this information was not
necessary to successfully determine the transformation matrices between the subsequent
US volumes.
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Figure 4.8 Voxel size assignment. A) CT of phantom with the lateral (12.03 cm) and
vertical (8.89 cm) measurements shown. B) US of phantom with the lateral (12.37 cm)
and vertical (9.05 cm) measurements shown.
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The accuracy and precision of US-US and US-CT registrations will determine
patient alignment/realignment but also the appropriate treatment margins within and
between fractions, respectively. The accuracy in phantom positioning (and thus
realignment) was determined by calculating the average difference in the translational
and rotational components of the transformation matrix between two registered volumes,
and the precision of these measurements by their standard deviation. Each US volume
was registered to its CT counter-point to determine the initial offsets between the US and
CT coordinate systems. Those measurements are shown in table 4.3. The average
translational offsets were -59.53±0.35 mm, -87.26±0.28 mm and 78.27±1.12 mm in the
X, Y and Z components, respectively; and their average rotational components were 1.47 ± 0.35°, 1.77 ± 0.88° and -0.08 ± 0.34° in the X, Y and Z. The small standard
deviations suggest high precision when registering US to CT.

Translational

X -59.23 ± 0.74

-59.93 ± 0.29

-59.73 ±1.20

-59.20 ± 0.26

-59.87 ± 0.21

-59.23 ± 0.38

-59.53 ± 0.62

Y -87.17 ± 0.47

-87.40 ± 0.78

-87.43 ± 0.57

-86.73 ± 0.67

-87.50 ± 0.44

-87.33 ± 0.12

-87.26 ± 0.53

Z

80.17 ± 1.23

78.23 ± 0.93

77.8 ± 0.00

78.73 ± 0.68

77.83 ± 0.45

76.83 ± 0.74

78.27 ± 1.24

Rotational

Table 4.3 US-CT translational [mm] and rotational [degrees] components of the transformation matrices
Flat
Wedge
5
15
30
45
Average

X

-1.63 ± 0.40

-1.43 ± 0.76

-0.80 ± 0.75

-1.83 ± 0.83

-1.50 ± 0.70

-1.60 ± 0.10

-1.47 ± 0.64

Y

0.50 ± 0.87

1.50 ± 0.10

-1.57 ± 0.40

1.53 ± 1.34

2.53 ± 0.67

3.00 ± 0.40

1.77 ± 1.04

Z

-0.13 ± 0.23

-0.50 ± 0.87

-0.30 ± 0.26

0.50 ± 0.78

0.00 ± 0.20

-0.07 ± 0.06

-0.08 ± 0.53
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We used the CT-to-CT registrations as the gold standard and US-to-US and USto-CT registrations to determine the precision in realignment. Each US volume was
registered to the phantom in the Flat position for US and CT. The US-to-CT
transformation matrices were subtracted from the average US-to-CT transformation
matrix from Table 4.3 to correct for different initial coordinate systems. The average
translational components and standard deviations of those transformation matrices are
shown in Table 4.4.
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Table 4.4 Translational [mm] and rotational [degrees] components of transformation
matrices. The wedge creates a 4° rotation about the x-axis. All other rotations are
about the y-axis
Translational
CT
X US-US
US-CT

Wedge→Flat
-0.6
0.31 ± 0.18
-0.93 ± 1.11

5→Flat
1.3
8.03 ± 0.55
1.17 ± 0.66

15→Flat
3.6
22.10 ± 0.20
7.80 ± 0.52

30→Flat
2.5
34.30 ± 0.20
20.23 ± 0.78

45→Flat
-3
35.00 ± 0.95
36.86 ± 0.46

CT
Y US-US
US-CT

4.7
9.46 ± -0.07
4.63 ± 0.67

4.3
8.93 ± 0.06
3.77 ± 0.72

3.3
8.27 ± 0.06
5.03 ± 0.23

1.8
6.70 ± 0.20
4.8 ± 0.44

0.4
4.43 ± 0.57
5.27 ± 1.18

CT
US-US
US-CT

-4.7
2.90 ± 0.26
-4.10 ± 0.38

1.4
13.03 ± 0.91
0.40 ± 1.04

14.8
39.70 ± 0.46
13.13 ± 1.04

35.6
83.97 ± 0.83
27.5 ± 0.57

55.1
126.20 ± 1.66
39.03 ± 1.15

CT
X US-US
US-CT

Wedge→Flat
3.6
4.01 ± 0.01
2.87 ± 0.90

5→Flat
3.7
3.93 ± 0.06
4.37 ± 0.85

15→Flat
4
4.30 ± 0.00
4.20 ± 1.01

30→Flat
4.4
4.83 ± 0.12
5.03 ± 0.51

45→Flat
6
5.77 ± 0.72
1.9 ± 2.52

CT
Y US-US
US-CT

0.4
-0.04 ± 0.06
0.70 ± 1.23

-4.3
-4.53 ± 0.31
-3.80 ± 1.21

-14.4
-14.70 ± 0.17
-14.30 ± 0.85

-29.6
-30.37 ± 0.31
-28.03 ± 0.81

-44.3
-44.50 ± 1.05
-42.57 ± 0.75

CT
US-US
US-CT

-0.1
-0.16 ± 0.06
-0.3 ± 0.44

-0.6
-0.40 ± 0.00
-0.43 ± 0.06

-1.3
-0.83 ± 0.06
0.80 ± 0.10

-3.1
-1.57 ± 0.15
0.30 ± 0.56

-4.5
-2.97 ± 0.72
0.33 ± 1.92

Z

Rotational

Z
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The variation in the translational offsets between CT, US-US, and CT-US can be
explained by the different point at which each volume was rotated around. The phantom
physically rotates around the center of the lazy susan, the CT volumes rotate around the
iso-center and the US volumes rotate around the corner of the volume. Identifying a
method to match the volume origins to remove this systematic error was unsuccessful.
For example, the DICOM origins could be matched in the contouring window of
EclipseTM, but didn’t carry over to the Registration window. We also attempted to pad the
volumes in MATLABTM, but a standard protocol could not be found to work for every
volume and processing each volume became too time consuming to be considered
practical in a clinical environment. Therefore, the procedure was abandoned. The
rotational components were not affected.
The statistical error, or precision, is determined from the standard deviations
within each group of registrations. Large statistical errors can’t be corrected for and call
for large target margins. For US-US registrations, the statistical errors were small, with
an average of 0.42, 0.19, 0.82 millimeters for the x, y and z translational components,
respectively, and an average of 0.18, 0.38 and 0.20° or the x, y and z rotational
components, respectively. Statistical errors from US-CT registrations were larger, an
average of 0.71, 0.65 and 0.84 mm for the x, y and z translational components,
respectively, and an average of 1.16, 0.97 and 0.62 degrees for the x, y and z rotational
components, respectively.
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4.4 Discussion
We have proposed to develop the tools necessary for clinics to implement
ultrasound guided RT using systems already available to most hospitals and fabricated
with inexpensive and low-Z materials. The US-platform was built out of acrylic and PLA
and provided a reproducible frame of reference for 3-D ultrasound volumes to be
registered to CT treatment planning scans. The platform doesn’t produce CT artifacts and
can be assembled quickly and easily while the patient is on the CT/RT couch. To test the
applicability of the US-platform, a rigid phantom comprised of agar, glycerin and water
was developed to represent the abdominal features seen in both CT and US. Under
different rotational and translation conditions found in the clinical, the US volumes were
imported into Eclipse and registered to CT after being processed in MATLABTM. The
resulting registration matrix elements were used to shift the couch to align the patient (or
phantom) to the treatment planning CT. Validating this technique when aligning canine
patients needs further investigation.
The patient is imaged via US and CT on the simulation bed to ensure the images
represent the same anatomy. The CT is used for treatment planning within Eclipse. US
volumes are taken with the patient on both the IMRT treatment couch and the CT bed,
and then registered to either the initial CT or US to determine couch shifts that will
realign the treatment images with the simulation images. We discovered that the process
of importing the US volumes to the treatment planning system was nontrivial, requiring
reformatting of the US volumes. When using the US-platform, there were a number of
uncertainties. One, the mechanical movement of the platform was within the 2 mm
acceptable tolerance defined by quality assurance procedures42 and detectable limits due
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to the precision of the couch. The phantom movement registrations were consistent with
previously reported accuracies43-45. The multimodal registration accuracy was much
worse due to the software not being able to register the volumes automatically. The
inability to automatically register US to CT presents an opportunity to improve the
precision of US greatly as a positioning tool.
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Table 4.5 Ultrasound platform measurements compared to quality assurance
guidelines from TG report 142
Positioning/repositioning
Planar kV and MV imaging

≤2 mm

kV and MV CBCT

≤2 mm

Ultrasound

0.21 ± 1.49 mm

Coordinate Coincidence
Planar kV and MV imaging
kV and MV CBCT
Ultrasound

≤2 mm
≤2 mm
1.99 ± 1.42 mm*

Ultrasound maximum 5° Rotation. Distance calculated from US-to-CT values
in Table 4.4
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While acrylic was adequate for building a prototype platform, it was too brittle to
effective as a long term tool without extreme caution taken to prevent wear and tear. The
3D printed materials would be more efficient, but the quality of the prints needs to be
improved or the design altered as the ability to print functioning parts has not been
perfected. We believe carbon fiber would be the ideal material.
Agar-based phantoms are inexpensive to make and with the addition of glycerin
to mimic different soft tissues; other centers should be able to duplicate the results
presented and explore different uses not considered by the authors. The authors believe
these US-platform designs promote further manufacturing and 3D printing studies for
tissue- and air-equivalent materials typically used in RT, such as carbon fiber. The
methods for importing ultrasound volumes into treatment planning systems will allow for
new multi-modal image fusion and registration studies to be investigated, such as power
Doppler.

4.5 Conclusion
The purpose of this work was to develop an ultrasound guidance system solely on
equipment available to nearly all institutions. Based on our results, patient setup
uncertainty is consistent with currently used techniques for positioning prostate patients if
couch-repositioning is less than a 5° rotation. Further investigation into the different
origins between US and CT may expand the conditions for which the registration
matrices accurately depict the couch shifts. Additionally, incorporating methods to
automatically register US to CT, such as point matching, will improve the precision of
the whole system. This work builds on the literature promoting ultrasound to be a viable
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option for image-guided RT, specifically for clinics not willing or not able to buy
commercially available equipment. Additional design considerations include the future
use of ultrasound-based functionality (photoacoustics, radioacoustics, Doppler) to
monitor blood flow46 and hypoxia47 and/or in-vivo dosimetry for applications in other
therapeutic techniques, such as hyperthermia, anti-angiogenesis and particle therapy48.
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CHAPTER 5. VALIDATING HEMOGLOBIN SATURATION AND DISSOLVED
OXYGEN IN TUMORS USING PHOTOACOUSTIC SPECTROSCOPIC IMAGING

5.1 Introduction
Photoacoustic tomography (PAT) is a noninvasive and nonionizing imaging
modality utilizing laser-induced ultrasonic signals. This imaging method merges the high
resolution of ultrasonic signals with the contrast being provided by optical scattering and
absorption. This allows for non-invasive structural and functional imaging in-vivo12.
Pulsed laser energy is absorbed instantaneously into the tissue, causing the tissue to
expand due to heating. The expanding tissues push against the surrounding tissue forming
an acoustic (or ultrasonic) wave which propagates at nearly constant velocity (vs). By
sampling the waves at various positions, the relative time (∆t) of the signals can be
utilized to determine the location and absorption of the molecule (r) (figure 5.1). Lastly,
either a 2D tomosynthesis algorithm or 3D filtered back-projection method is used to
form an image49. Note, hemoglobin is the largest absorber of near infrared energy in the
tissue, allowing for the imaging of hemoglobin concentration and the percentage of
oxygenated hemoglobin (SaO2) through near infrared spectroscopy.
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Figure 5.1 Photoacoustic principles. Pulsed laser energy is absorbed instantaneously into
the tissue, causing the tissue to expand due to heating. The expanding tissues push against
the surrounding tissue forming an acoustic (or ultrasonic) wave which propagates at
nearly constant velocity (vs). By sampling the waves at various positions, the relative
time (∆t) of the signals can be utilized to determine the location and absorption of the
molecule (r).

74
The goal of these experiments is to validate the relationship between SaO2 and
pO2 in breast tumors in mice using photoacoustic computed tomographic imaging and
OxyLite probe, respectively, and to determine the feasibility of translating this
technology into a clinical setting. In its simplest form, the relationship between SaO2 and
pO2 is described by the dissociation curve for hemolgobin, or Hill’s equation, and is
modeled as a sigmoidal curve that is a function of two parameters – the Hill coefficient,
n, and the net association constant of HbO2, K or p50 (or pO2 at 50% SaO2).
(𝑝𝑂2 )𝑛
𝑆𝑎𝑂2 = 𝑛
𝐾 + (𝑝𝑂2 )𝑛

(5.1)

First, a calibration study to validate Hill’s equation in blood was performed by
creating a closed circuit phantom to test the SaO2 (682 Co-Oximeter System, Instrument
Laboratory Inc., Ramsey, Minnesota) and pO2 (Oxylite probe) relationship. Next, noninvasive localized measurements of SaO2 in MDA-MD-231 and MCF7 breast tumors
using PCT spectroscopic methods were compared to pO2 levels in vivo.

5.2 Methods

5.2.1

Phantom Model

In Figure 5.2(A), a closed circuit system was constructed to simulate the flow of
blood in a blood vessel. A tonometer was used to mix or bubble various concentrations of
air and nitrogen in the blood by varying their relative partial pressures in order to control
pO2 and SaO2 levels. A capillary pump was used to mix the gases throughout all the
entire blood volume. The OxyLab Series E oxygen and temperature integrated probe was
placed within the tonometer to measure the pO2 (mmHg). The probe employs a
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phosphorous quenching technique using fiber optics. The tip of the probe releases light,
which excites the phosphor. The phosphor molecules release energy, which bonds to an
oxygen molecule. The amount of O2 is determined using the Stern-Volmer
phosphorescence decay equation. The co-oximeter was used to measure the SaO2 in a
sample of blood (0.3-0.5 mL) extracted from the circuit. These two measurements were
plotted and fit to Hill’s equation to obtain K [mmHg] and n.
In the second experiment, the blood was circulated in FEP tubing through a
phantom filled with water, and exposed to light produced from a YAG laser and OPO
tuned to the wavelengths of 700 and 850 nm. An ultrasound transducer (or transducer
array) was used to measure the photoacoustic signals. To determine the SaO2, a system of
linear equations was solved, which was based on the laser induced pressure signals.
[𝐻𝑏] ∗ 𝜇1,𝜆1𝐻𝑏 + [𝐻𝑏𝑂2 ] ∗ 𝜇1,𝜆1 𝐻𝑏𝑂2 = 𝜇𝜆1

(5.2)

[𝐻𝑏] ∗ 𝜇2,𝜆2𝐻𝑏 + [𝐻𝑏𝑂2 ] ∗ 𝜇2,𝜆2 𝐻𝑏𝑂2 = 𝜇𝜆2

(5.3)

These SaO2 measurements were compared to the values obtained from the co-oximeter.
Next, the phantom was then imaged with a 128 element linear transducer array and
reconstructed using a delay and sum reconstruction algorithm.
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Figure 5.2 Blood circulation system design. A) Phantom setup B) photoacoustic
spectroscopy setup. By inducing a pressure wave at two different wavelengths and
recording the amplitude with an ultrasound transducer, the concentrations of oxy- and
deoxyhemoglobin can be calculated by solving a system of linear equations
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5.2.2

Mouse Model

MDA-MD231, MCF7 and MCF7/VEGF cells (1-5x106) were injected into the
mammary fat pads of athymic nude mice. Tumors were allowed to reach a diameter of
approximately 8-12 mm and then spectrally imaged within photoacoustic computed
tomographic scanners (Small Animal Photoacoustic Scanner, Optosonics Inc.,
Indianapolis, IN). The Oxylite probe was used to measure the pO2 values within these
tumors by inserting a needle across the central axis of the tumor (using calipers) and then
inserting the probe tip through a needle. Measurements were taken every 1 minute in 1
mm increments. Photoacoustic images prior to and after the probe was inserted into the
tumor were used to determine the insertion path (line) of the probe from which the SaO2
values were measured. Scatter plots of the SaO2 and pO2 values were fit to Hill’s
equation to obtain K and n using the curve fit tool in MATLABTM.

5.3 Results

5.3.1

Phantom Model

The measurements in our phantom yielded an n of 2.26 (2.09, 2.43 95%
confidence interval) and K (p50) of 23.4 mmHg (22.5, 24.3 95% confidence interval) for
a solution to Hill’s equation,
𝑆𝑎𝑂2 =

(𝑝𝑂2 )2.265
23.412.265 + (𝑝𝑂2 )2.265

(5.2)

with an R2 = 0.997 shown in Figure 5.3A. The SaO2 calculations from the laser induced
photoacoustic signals correlated very well with the co-oximeter measurements (R2 =
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0.981) above 65% SaO2. The calculations diverged when the SaO2 fell below 65%. The
lowest photoacoustic measured SaO2 was 57% whereas the co-oximeter measured 15%.
The phased array reconstruction of the 1.1 mm wire filled with blood shown in Figure
5.4A has a FWHM of 1 mm in the axial direction and 2 mm in the lateral direction.
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A

B

Figure 5.3 Phantom Results. A) Graph of calibration data (∆) with Hill’s equation fit line
(magenta line). B) Photoacoustic vs. Co-oximeter measured SaO2 values
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Figure 5.4 PA Image Reconstruction. A) Phased array photoacoustic reconstruction of
1.1 mm tube filled with blood. B) Intensity profiles
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5.3.2

Mouse Model

The SaO2 values along the insertion line of the OxyLite probe was determined by
fitting the photoacoustic CT images spectral data to oxy- and deoxy-hemoglobin optical
absorption curves.. Images showing the spectroscopy analysis are shown in Figure 5.5. In
this example, the SaO2 values for voxels of low, moderate, and high oxygenation were
calculated with reduced chi squared values of 0.51 for a SaO2 of 5.9%, 0.41 for 52.5%
and 0.32 for 85%, representing good fits for a range of conditions. Plots of SaO2 versus
pO2 were fit to Hill’s equation to obtain K and n for both the MCF7 and MDA-MD-231
strains of breast cancer. The MCF7 data showed a reduced K value of 17.2 mmHg
compared to the calibration curve (p50 of 23.5 mmHg) and 1.76 for Hill’s coefficient.
The data obtained from the MDA-MD-231 tumor measured a K value of 20.7 mmHg and
1.63 for the Hill coefficient.
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Figure 5.5 Spectroscopy analysis. The different graphs exemplify the oxygenation of the
respective voxel in the image. They also display the respective SaO2 values for each
voxel. The image range from low oxygenation to high oxygenation in the following
order: A, B, C.
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Figure 5.6 Dissociation curves for the mouse models. A) Graph displaying MCF7 data
(∆), the Hill’s equation fit (gold line) and the calibration fit (magenta line). B) Graph
displaying MDA-Md231 data (*), the Hill’s equation fit (blue line) and the calibration fit
(magenta line).
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5.4 Discussion
The objective of this study was to calibrate and validate photoacoustic
measurements of the local SaO2 in tumors correlates to the oxygen concentration pO2 as
measured by the OxyLite probe (Gold Standard). Experiments were performed to
measure both oxygen levels and oxygen saturation levels in blood within phantoms and
tumors. First, a blood phantom was designed and used to successfully measure the
dissociation curve for RBCs. Based on fits to Hill’s equation, K (or P50) of 23.4 mmHg
and an n of 2.26 was determined, and within the expected range of 20-25 mmHg50,51. This
same technique was applied in xenograft mouse models bearing MCF7 and MBA-MD231 breast tumors, and measured a shift or lower P50 value in the dissociation curve. For
MCF7 tumors, the K value was 5.8 mmHg lower compared to calibration blood curves,
17.2 mmHg compared to 23.4 mmHg. However, a number of factors can cause such a
shift, such as temperature, pH, and DPG.
Given that tumors are known for acidosis (reduced pH), this shift is believed to be
related to the pH formed within the tumor52,53. However, the K value for MDA-MB-231
is within the expected range at 20.7 mmHg. Acidosis is known to vary within a tumor and
for different tumor types, and could explain these results; however, further analysis is
necessary to assess significance and validate this hypothesis. For the parameter n, they
were also lower than calibration values, 1.76 and 1.63 respectively. This suggests a
variation in cooperative binding within hemoglobin, which appears unlikely54. As with K
value, further statistical analysis is ongoing to determine if these differences are
significant.
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5.5 Conclusions
Overall, the results from this study demonstrate that PCT-S can provide measures
of intra-tumor oxygenation. To date, these are the first known measurements comparing
the SaO2 levels obtained from photoacoustic imaging to a gold standard for pO2.
However, some issues remain: difference in K and n to that of the calibration curve, and
scatter in the data.
Our next step is to reduce the uncertainty (systematic and statistical) in the data.
An important factor is the variation in the photon fluence based on radiative transport of
the laser light through the tumor. Given that the light at a point deep within a tumor
depends on the absorption properties of the tumor prior to reaching this point, systematic
errors in the spectral data can occur and need to be corrected. Similarly, image artifacts
due to incomplete sampling can influence spectral data and will need to be corrected.
Finally, devising a technique to better determine the location of the probe passes through
the tumor will help reduce scatter in the data.
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CHAPTER 6. DISCUSSION

Although the work was targeted around canine TCC, applications can include
many abdominal cancers shown to have favorable outcomes with radiation therapy. The
American Cancer Society predicts over 150,000 deaths from cancer of the digestive tract,
over 30,000 deaths from cancer of the urinary system and over 40,000 deaths from breast
cancer in 201655. Although CBCT is the standard patient positioning technique, this work
builds on the literature promoting ultrasound to be a viable option for image-guided RT.
Specifically, for clinics that do not have a linear accelerator with CBCT capabilities and
are not willing or not able to buy commercially available equipment.
Convincing clinics that do utilize kV imaging systems and CBCT for many of
their treatment protocols to switch to US will be a tall order. Many of the diseases occur
in elderly patients where the long-term, cumulative imaging dose is not a concern. The
latency period, defined as the time from initial exposure to occurrence of malignancy
induced by radiation was estimated to be between 5 and 15 years56. One group that would
greatly benefit from a non-radiographic imaging modality is pediatrics, especially as
treatments improve and the life expectancy post cancer moves beyond the latency period.
An estimated 10,380 children (aged 1 to 14) will be diagnosed with cancer, with 1,250
expected to die from the disease55. Finding data on the dose delivered from the many
different radiographic imaging modalities has proven difficult. Different imaging
modalities deliver very
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unique spatial distributions of dose. Consequently, the physiological risks can be
considerably different9. Work on assessing patient organ doses resulting from CBCT has
become an area of active research57. The most efficient way to remove concerns of risk
from imaging dose is to remove as much as the imaging dose as possible from the
procedure. Ultrasound provides a viable alternative.
In addition to removing the imaging dose from patient setup, US can provide
intrafractional monitoring of organ motion throughout treatment without the use of
ionizing radiation or implanted fiducial markers. Intrafractional monitoring of organ
motion is critical to delivering the correct dose to the target as well as not over irradiating
the healthy surrounding tissue. The investigation of internal organ motion, deformation,
and the dosimetric impact of these changes has been studied and summarized58.
Concluding that the changes are significant and that intrafractional monitoring of the
changes may be necessary.
Until recently, non-radiographic localization systems have been limited to
infrared cameras, implanted radiofrequency and ultrasound9. The literature reports that
using infrared cameras for surface tracking is a poor surrogate for prostate motion59,60 and
the correlation with disease sites in the thorax and abdomen is inconclusive.
Radiofrequency devices need to be implanted, which can be invasive. Additionally, they
still don’t truly report organ motion, only movement of the device, which may not give a
clear picture of the internal anatomy. Using MRI is a new technique for IGRT. As more
systems get installed, data on the functionality and limitations will become available.
Looking forward, we will have to wait see if being limited to a cobalt-60 source and not
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having access to an electron beam significantly affect the widespread adoption of these
systems.
The advantage of ultrasound is the ability to image internal anatomy without the
use of ionizing radiation or implanted devices. Our system specifically addresses
deficiencies in currently available systems, such as free-hand probe manipulation, and
designed with the ability to incorporate a fluid filled bolus to remove distortions caused
by probe pressure. Where our system doesn’t match those that are commercially available
at this time is the online communication with record and verify systems to utilize the
intrafractional organ motion. Software development that is beyond the purpose of this
study will be necessary to include these features.
Given the translational validation of the US for clinical treatment of canine
patients, our focus is toward the feasibility of using PCT to provide new imaging
properties and link this to tumor radiation sensitivity and immune response of the patient.
The goal being to be able to provide structural and functional information, much like
PET/CT, but without the use of any ionizing radiation and in a way that can be
incorporated into the radiation therapy suite. Angiogenesis, the production of new blood
vessels is considered to be one of the integral hallmarks of cancer61. The presence of
hypoxia and cell proliferation rate, features unique to the tumor, are important factors in
radiation treatment response62.
The results from the PCT-S demonstrate that PCT-S can provide measures of
intra-tumor oxygenation. To date, these are the first known measurements comparing
photoacoustic SaO2 to a gold standard for pO2. Additionally, the resolution in our
preclinical phantom measurements was better using a phased array reconstruction for
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linear transducers (FWHM of 1 mm in axial, 2 mm in lateral) than PET (≈5 mm)63 and
SPECT (>15 mm)64. These measurements open up the door for imaging the heterogeneity
of the tumor with high resolution. Dose painting is the prescription of a non-uniform dose
distribution based on function information relating to the radio-resistant or radio-sensitive
regions of the tumor. The hypothesis being, 1) the micro-environment of the tumor
contains radio-resistant regions that lead to recurrence, 2) molecular and functional
imaging of these regions will allow for mapping the heterogeneity of the tumor and 3)
boosts to these regions will improve tumor control without increasing radiation induced
toxicity65.
Problems with implementing PET and SPECT for dose painting arise from the
poor inherent resolution of the systems and an unacceptable dose to the patient from
repeated scans. Photoacoustic imaging may provide the resolution necessary to properly
visualize the radio-resistant regions of the tumor and because no radiation dose is
associated with this technique, multiple scans can be acquired to monitor the change in
the tumor microenvironment. Additional design considerations include the future use of
ultrasound-based functionality (photoacoustics, radioacoustics, Doppler) to monitor
blood flow46 and hypoxia47 and/or in-vivo dosimetry for applications in other therapeutic
techniques, such as hyperthermia, anti-angiogenesis and particle therapy48.
Another unique application of photoacoustics is in particle therapy. The bragg
peak associated with particle therapy creates a similar pressure wave that can be
measured as a function of absorbed dose. This provides a novel technique for in-vivo
dosimetry48, a major concern with the sharp dose gradients associated with particle
therapy. Only recently has CBCT made its way into proton therapy treatment rooms. The
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high temporal resolution of US, molecular PA imaging and treatment planning combined
with in-vivo dosimetry has yet to be accomplished and has the ability to revolutionize
radiation therapy.
As mentioned earlier, In-vivo models including complete physiologic processes
such as multiple organ interactions, angiogenesis and the immune system are necessary to
improve current in-vitro models3. It is critical to understand that the response to treatment
in terms of tumor control and toxicity is often unique to individual patients. It has been
shown that the expression of particular molecules in the tumor can be linked with either
predicting certain outcomes from treatments or a change in prognoses66,67.
The general hypothesis is that blood cytokine levels present prior to RT and
during the course of treatment will be correlated with tumor control. We conducted a
pilot study (N=3) investigating the production of cytokines in response to RT (complete
data in Appendix B). Baseline cytokine levels comparing our control group (patients in
the hospital for orthopedic evaluation) to our cancer subjects can be seen in Table 6.1.
We found concentrations of Interleukin(IL)-10 (anti-inflammatory) to be significantly
reduced (p=0.05) in cancer patients than control, whereas IL-8 (inflammation and
hypoxia), Monocyte Chemoattractant Protein (MCP)-1 (regulates
monocytes/macrophages) and Chemokine Ligand (CXCL)-1 (also known as KC-like,
angiogenesis) to be significantly increased in the cancer patients compared to control.
Many of the cytokines we investigated are associated with inflammation and
angiogenesis, biomarkers that can be used to validate the efficacy of dose painting and
radiation therapy in general.
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Table 6.1. Mean control and cancer patients
before treatment with the ranges (min-max)
shown in parentheses
Control

Baseline

IL-10

61.38*
(0-178.35)

25.33
(8.7-55.61)

IL-2

0

0

IL-6

11.05
(0.27-28.39)

3.23
(0-5.9)

IL-8

4907.3
(3523.75-7241.35)

8717.77*
(5016.12-13481.01)

MCP-1

89.23
(0-267.68)

220.77*
(0-402.4)

TNF-α

0

0

KC

651.92
(351.35-1197.58)

1480.43*
(592.41-2811.42)

*P=0.05
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CHAPTER 7. CONCLUSIONS AND FUTURE DIRECTIONS

The overall purpose of the first part of this work was to present methods for
developing an ultrasound guidance system solely on equipment available to nearly all
institutions. Although US yielded poorer resolutions than CBCT, the theoretical
uncertainty, taking into account all the underlying physical principles of US, beam
formation, and artifacts, still allowed us to register US to CT with errors under the 2 mm
recommendation.
Based on our results, the initial hypothesis that US would reduce the uncertainty
in delineating tumor margins remains unsolved. Experiments modeling deformable
registration and intrafactional motion will be necessary to conclude whether smaller
planning target volumes can be applied to the bladder. The work builds on the literature
promoting ultrasound to be a viable option for image-guided RT, specifically for clinics
not willing or not able to buy commercially available equipment. As is the case at the
Purdue University Teaching Hospital, where patients with bladder cancer are not eligible
for RT because of the inability to accurately visualize the bladder at patient setup.
Additionally, the procedures for importing images and volumes into the treatment
planning system has not been previously reported. These methods will allow future
studies to investigate the use of other imaging modalities in a treatment planning
environment.
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As with any engineering endeavor, the development never ends. Future work
should address the brittleness of the acrylic components. Ideally, the next design should
be built from carbon fiber. A more robust prototype will facilitate long-term acceptance
testing, where spatial reproducibility and drift can be assessed. Assuming those pass, only
the development of communication with record and verify systems will be necessary to
implement this technology.
The second half of this study investigated the use of photoacoustic tomography to
identify intra-tumor hypoxic variations impacting radiation response and outcome.
Overall, the results from this study demonstrate that PCT-S can provide measures of
intra-tumor oxygenation. To date, these are the first known measurements comparing
photoacoustic SaO2 to a gold standard for pO2. However, some issues remain: difference
in K and n to that of the calibration curve, and scatter in the data.
Our next step is to reduce the uncertainty (systematic and statistical) in the data.
An important factor is the variation in the photon fluence based on radiative transport of
the laser light through the tumor. Given that the light at a point deep within a tumor
depends on the absorption properties of the tumor prior to reaching this point, systematic
errors in the spectral data can occur and need to be corrected. This is will be a
challenging task as the technology moves from small to larger animals to humans. In
addition, implementing a reconstruction algorithm based on a linear US transducer array
will be necessary to truly fuse the anatomical and functional imaging to a single
modality.
The final phase of this study was to evaluate the production of cytokines in canine
patients with fully intact immune systems and spontaneous cancer, much like the way
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cancer effects human patients. Potentially identifying advantageous cycling of radiosensitivity and/or radio-resistance during the course of RT.
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Appendix A

Phantom Artifacts

Improvements in ultrasound (US) image fidelity are needed to target features of
radioresistance and radiosensitivity. Additionally, the accuracy and precision of 3D
ultrasound guided radiation therapy (US-GRT) may be improved by enhancing the image
quality of US images. A number of US artifacts; such as speckle, reverberation, refraction
and speed of sound displacement, were exaggerated in our phantom compared to clinical
images and attempts to remove, reduce or quantify these artifacts are presented in this
section. For each of these factors, the data acquired from chapter 4 will be analyzed. We
believe the position of the target in the FOV plays a critical role on what artifacts are
seen. We know that refraction and the speed-of-sound will distort the image. The idea is
to correct each method-of-distortion independently. All of the image processing was done
in MATLABTM and details on the individual functions and filters can be on their website.
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Figure A.1 Phantom Artifacts. Image of phantom showing different artifacts identified.
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First, the built in wiener function in MATLABTM was used to reduce speckle. The
function ‘wiener2’ lowpass-filters a grayscale image that has been degraded white noise.
Wiener2 estimates the local mean and variance around each pixel. We found that a 10by-10 region provided the best outcome. This function smooths the speckle noise while
preserving high frequency edges. Secondly, the vertical intensity profiles for each image
slice were digitally high-pass filtered. We used the MATLAB function
y = filtfilt(b,a,x) to digitally filter our data by processing the input data, x, in both the
forward and reverse directions to cancel out the phase shift added to signals only
processed in the forward direction.

Figure A.2 Speckle reduction. The original (A), the wiener filtered (B) and the high-pass FIR filtered (C) images are shown. The
speckle background noise is visibly smoother while the high frequency objects are preserved. Intensity profiles (D) through the three
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high-frequency objects in the right center are shown.
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The next step was to remove the reverberation artifacts. Each image was
normalized to have intensity values from 0-1. By definition, the reverberation artifact will
have the same frequency as the original features. Therefore, we can set a region of
interest around the artifacts and apply a fourier transform to determine their frequency.
Next, set a high-pass filter above the frequency of the features. Lastly, the high-pass
digitally filtered images were subtracted from the original image to remove artifacts of
interest.

Figure A.3 Reverberation reduction. The wiener filtered (A), the high-pass filtered (B), and the stubtracted images (C) are shown.
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Intensity profiles (D) through the three high-frequency objects in the right center are shown.
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The speed-of-sound correction algorithm is in effect a non-linear sampling
problem, and with some simple assumptions, can be reversed engineered and through
interpolation methods a corrected image produced. Images can be segmented (skin, soft
tissue, bladder) and resampled with the appropriate speed of sound. There is exhaustive
literature on speed of sound correction algorithms discussed in Chapter 3.
Refraction is a fairly complicated artifact and very difficult to correct. First, we
can calculate the change in depth as a function of lateral displacement (Figure A.3) by
applying Snell’s law.
𝜋
𝛿𝑥 = 2 ∗ 𝑅 ∗ sin ( ) ∗ sin(𝜃𝑡 − 𝜃𝑖 )
2
sin𝜃𝑡 =

(A.1)

𝑐2
∗ sin(𝜃𝑖 )
𝑐1

(A.2)

𝑥
𝑅

(A.3)

sin𝜃𝑡 =

Utilizing these fundamental equations, the total propagation length and time can be
calculated as a function of x, with and without refraction.
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Figure A.4 Refraction quantitated. A) Refraction diagram, B) effects of refraction and
SOS between depths of 30-60mm and B) 0-8 mm.
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In summary, tissue heterogeneity (fat versus bladder) distorts margins by
approximately 1.0 mm. The error in the lateral displacement can exceed 1 mm when the
lateral distance exceeds R/2. The effect is to flatten the bladder and reduce its volume.
Work with spatial compounding protocols may improve edge detection when refractive
artifacts are present. In terms of the other artifacts, efforts to isolate and remove speckle
and reverberation blurred the edges of the bladder and reduced the volume of the bladder
when automatic edge detection methods were applied.
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APPENDIX B

Cytokine Data

The Canine serum 8-plex (Il-2, IL-6, IL-8, IL-10, MCP-1, TNFa & KC) cytokine
assay ran without any issues. The data shown shows average concentration values of
replicate wells. If the value falls outside the standard curve, this will be denoted by
“OOR<” or “OOR>” (Out of Range) in this column. Extrapolated concentrations were
calculated by the BioPlex software on values that are outside of the range of the standard
curve. The software also calculated values for wells with negative fluorescence
(fluorescence below the background fluorescence). These are marked with an asterisk.
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Table B.1 Results of the Luminex bead panel. Concentrations are in
[pg/ml].
IL-10

IL-6

IL-8

MCP-1

KC

PreSerum

*11.69

*3.79

13481.01

402.4

2811.43

PostSerum

41.28

*3.09

7874.49

404.13

1922.7

Day3

*16.79

*3.09

16231.3

371.74

3034.4

PreSerum

55.61

*5.90

5016.12

259.92

592.41

PostSerum

60.07

*1.68

2963.01

181.05

455.68

Day3

52.28

*3.09

4394.8

331.97

541.16

FinalSerum

39.1

*3.09

4932.16

311.33

700.74

PreSerum

*8.70

OOR <

7656.18

OOR <

1037.46

PostSerum

*19.90

*4.50

5035.9

OOR <

810.17

Day3

*17.30

OOR <

7298.83

OOR <

1091.74

FinalSerum

*24.09

77.59

5182

456.22

2159.41

Serum

OOR <

*5.20

6992.47

377.76

1332

control 1

*5.78

*28.39

3956.81

267.68

351.35

control 2

OOR <

*4.50

7241.35

OOR <

1197.58

control 3

178.35

*0.27

3523.75

OOR <

406.83

Patient 1

Patient 2

Patient 3

*Calculated values for wells with a negative fluorescence. IL-2 and
TNF-α were below the detectable limit for all measurements
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Patient 1 Medical History. Patient 1 is a castrated 10 year old male Golden
Retriever. Patient 1 first presented to the PUVTH medical oncology department on
5/15/15 for evaluation of two fast growing masses on the right shoulder and cranial
sternum. The owner noticed these two masses about 3 weeks from that date. The other
masses along his body have been present for approximately two years according to the
owner. Patient 1 has no history of any other medical problems. His growing masses were
biopsied and it was determined that the mass on Patient 1’s right shoulder was consistent
with a soft tissue sarcoma (special stains were negative for histiocytic sarcoma or
hemangiosarcoma) and the one on his sternum was consistent with lipoma.
Punch biopsies from both cutaneous masses were submitted for microscopic
evaluation. The biopsy of soft tissue from the right shoulder contained a proliferation of
atypical spindle and round cells with indistinct cell limits, moderate to abundant
amphophilic cytoplasm and large round to pleomorphic nucleus with single or multiple
nucleoli. There were 16 mitotic figures per 4 hpf, some atypical. More than 70% of this
sample contains necrotic tissue and mixed leukocytic infiltrates in addition to septal
fibrosis.
The atypical round/spindle cells with large nucleus were negative for CD18.
Some foamy cells interpreted as macrophages as well as many small round cells
interpreted as leukocytes were CD18 positive. The atypical cells were CD31 negative.
The atypical cells were not considered to be of leukocytic or endothelial origin, leaving
the diagnosis of soft tissue sarcoma unmodified to this point.
Patient 1 was taking Tramadol 50mg tablets (3 every 8-12 hours), Clavamox
375mg tablets (2 every 12 hours) and Metronidazole 500mg tablets (1 every 12 hours)
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Tramadol is a synthetic opioid that helps to alleviate pain. Possible side effects include
sedation, respiratory depression and GI upset. Clavamox medication is an antibiotic and
is given around the time of a meal to help avoid adverse side effects, such as nausea,
vomiting, diarrhea or a decrease in appetite from occurring. Metronidazole is an
antibiotic for soft stools and diarrhea.
Patient 1 received only 3 out of 5 fractions. Our goal was to stabilize the size or
shrink down the tumor in size for a period of time with RT, effectively control the local
disease with minimal side effects. The mass has been stable in size since the beginning of
RT, however there is progression on the surface of the skin, where the mass has been
progressively protruding and bleeding. The mass has been growing rapidly in the 2 weeks
since prescribing treatment to treatment delivery, which is consistent with a high grade
tumor. Due to Patient 1’s quickly degrading quality of life, it was recommended to
discontinue RT and humanly euthanize.
Patient 2 Medical History. Patient 2 is a spayed female chocolate Labrador
retriever, 8 years and 9 months in age. On 4/15/2015 the mass on Patient 2’s right flank
was first found on routine health exam at an animal clinic not affiliated with PUVTH. A
fine needle aspirate/cytology revealed atypical mesenchymal cells. A biopsy of the mass
was then taken on 4/20/2015 which revealed low grade nerve sheath tumor. Tumor cells
extended into the margins. Mitotic index was found to be 4 per 10 HPF. On 5/28/2015
Patient 2 presented to the PUVTH for further evaluation of the tumor. On CT scan a
single nodule was found on the right adrenal gland (2.1 cm x 1.5 cm). On 6/8/2015
Patient 2 presented to PUVTH for palliative RT treatment of her nerve sheath tumor and
right adrenal mass. Patient 2 has been doing well at home and has been eating and
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drinking well. No sneezing, coughing, diarrhea or vomiting has been observed since the
last visit.
Patient 2 has been on Tramadol 50mg tablet (2 every 12 hours),
Phenoxybenzamine 9mg capsule (1 every 12 hours) and Metronidazole 250mg tablet (2
every 12 hours). Phenoxybenzamine is to control blood pressure in the case the adrenal
tumor is pheochromocytoma, which causes hypertension. No present side effects related
to the medications.
Patient 2 received a total of 5 daily doses of 4 Gy each. Patient 2 received
palliative RT for both the peripheral nerve sheath tumor, as well as right adrenal gland
mass. Palliative RT is performed to stabilize or potentially shrink the tumor in size, the
goal not being to cure the tumor, but to control the local disease for a time with minimum
side effects. Good quality of life are very important.
Patient 3 Medical History. Patient 3 is a castrated English Springer Spaniel, 10
years and 11 months in age. Patient 3 presented to the PUVTH Radiation Oncology
service for repeat evaluation of a previously irradiated nasal tumor. Patient 3 was
diagnosed with a nasal tumor via CT scan in June of 2015 which could not be definitively
diagnosed due to positioning and small samples. Patient 3 underwent palliative RT
following this which was completed on 6/12/2015.
Patient 3 has mucus discharge coming from his left nostril and more serious
discharge coming from his right nostril. No epistaxis has been seen since his previous
visit. Patient 3 has seemed uncomfortable trying to sleep at night when there is a lot of
discharge. He is eating and drinking well and he has not had any coughing, sneezing or
GI upset.
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Multiple fragments from a mass in the right nasopharynx were submitted for
microscopic evaluation. Some samples consisted of normal nasal conchae, others are
partially lined by pseudostratified respiratory epithelium and contain a submucosal
proliferation of islands and cords of atypical polygonal cells with distinct cell limits,
moderate amphophilic cytoplasm and large round nucleus with single or multiple
nucleoli. Nuclear atypia was moderate with some karyomegalic cells. Abundant
fibrocollagenous stroma surrounded variably sized aggregates of neoplastic cells. There
were 25 mitotic figures per 10 hpf. There were extensive areas of necrosis. A set of
samples consisted of haired skin with expansion of the dermis and subcutis by fibrosis
and mixed infratrates of leukocytes (plasma cells, macrophages, lymphocytes and
neutrophils). The inflammation extended to the adjacent skeletal muscle. Neoplastic
growth was not observed in these samples.
Patient 3 was prescribed Tramadol 50 mg tablets (1.5 tablets by mouth every 8-12
hours), Prednisone 10mg tablet (1 by mouth every 24 hours), Keppra 500 mg tablet (1.5
by mouth every 8 hours) and Genteal Gel (1/4 in strip to both eyes once every 8 hours).
Prednisone is a steroid medication to reduce inflammation. Keppra (aka Levetiracetam) is
an anti-convulsant medication. Genteal Gel is a topical lubricant.
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